11C- and 18F-Radiotracers for In Vivo Imaging of the Dopamine System: Past, Present and Future.
Michael R KilbournPublished in: Biomedicines (2021)
The applications of positron emission tomography (PET) imaging to study brain biochemistry, and in particular the aspects of dopamine neurotransmission, have grown significantly over the 40 years since the first successful in vivo imaging studies in humans. In vivo PET imaging of dopaminergic functions of the central nervous system (CNS) including dopamine synthesis, vesicular storage, synaptic release and receptor binding, and reuptake processes, are now routinely used for studies in neurology, psychiatry, drug abuse and addiction, and drug development. Underlying these advances in PET imaging has been the development of the unique radiotracers labeled with positron-emitting radionuclides such as carbon-11 and fluorine-18. This review focuses on a selection of the more accepted and utilized PET radiotracers currently available, with a look at their past, present and future.
Keyphrases
- pet imaging
- positron emission tomography
- computed tomography
- uric acid
- high resolution
- prefrontal cortex
- pet ct
- case control
- metabolic syndrome
- blood brain barrier
- quantum dots
- resting state
- binding protein
- mass spectrometry
- white matter
- functional connectivity
- cerebral ischemia
- fluorescent probe
- photodynamic therapy
- dna binding
- fluorescence imaging